Abits
ABTS
CleanSpark
CLSK
SATO TECHNOLOGIES CORP
CCPUF
FRMO CORP
FRMO
DMG BLOCKCHAIN SOLUTIONS INC
DMGGF
US Stock MarketDetailed Quotes
SGMO Sangamo Therapeutics
- 1.080
- -0.085-7.30%
Close Jan 13 16:00 ET
- 1.090
- +0.010+0.93%
Post 19:59 ET
225.34MMarket Cap-1.52P/E (TTM)
1.150High1.030Low6.73MVolume1.120Open1.165Pre Close7.23MTurnover3.30%Turnover RatioLossP/E (Static)208.65MShares3.17952wk High5.74P/B220.36MFloat Cap0.30452wk Low--Dividend TTM204.04MShs Float51.375Historical High--Div YieldTTM10.30%Amplitude0.291Historical Low1.073Avg Price1Lot Size
About Sangamo Therapeutics Company
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.
Company Profile
SymbolSGMO
Company NameSangamo Therapeutics
Listing DateApr 6, 2000
Issue Price15.00
Founded1995
CEODr. Alexander Donald Macrae, M.B.,PhD
MarketNASDAQ
Employees405
Fiscal Year Ends12-31
Address501 Canal Boulevard
CityRichmond
ProvinceCalifornia
CountryUnited States of America
Zip Code94084
Phone1-510-970-6000
Websitehttp://www.sangamo.com
Company Executives
- Name
- Position
- Salary
- Dr. Alexander Donald Macrae, M.B.,PhD
- Director, President and Chief Executive Officer
- 2.39M
- Nathalie Dubois-Stringfellow, PhD
- Senior Vice President and Chief Development Officer
- 1.03M
- Prathyusha Duraibabu
- Senior Vice President, Chief Financial Officer and Principal Accounting Officer
- 1.06M
- Amy Pooler, PhD
- Vice President and Head of Research
- --
- Scott B. Willoughby
- Senior Vice President, General Counsel and Corporate Secretary
- --
- Dr. Karen L. Smith, L.L.M.,M.B.A.,M.D.,PhD
- Independent Director
- 76.78K
- Courtney Beers
- Independent Director
- 73.24K
- James R. Meyers
- Independent Director
- 78.66K
- Margaret A. Horn, J.D.
- Independent Director
- 71.25K
- Dr. Kenneth J. Hillan, Ch.B.,M.B.
- Independent Director
- 71.16K
- Robert F. Carey
- Independent Director
- 80.53K
- Dr. John H. Markels, PhD
- Independent Director
- 76.78K
- H. Stewart Parker
- Chairwoman of the Board
- 99.28K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
